Biogen Inc. buy matumba
Start price
07.12.11
/
50%
€83.50
Target price
10.05.12
€102.75
Performance (%)
23.28%
End price
10.05.12
€102.94
Summary
This prediction ended on 10.05.12 with a price of €102.94. The prediction had a final performance of 23.28%. matumba has 50% into this predictionPerformance without dividends (%)
| Name | 1w | 1m | 1y | 3y |
|---|---|---|---|---|
| Biogen Inc. | -3.457% | -3.457% | 2.089% | -45.522% |
| iShares Core DAX® | -1.212% | 1.925% | 17.589% | 68.786% |
| iShares Nasdaq 100 | -4.714% | -1.810% | 0.450% | 100.066% |
| iShares Nikkei 225® | -2.976% | -2.660% | 10.156% | 43.024% |
| iShares S&P 500 | -2.744% | -0.448% | 0.320% | 63.222% |
Comments by matumba for this prediction
In the thread Biogen Inc. diskutieren
38% Gewinnsteigerung
38% Gewinnsteigerung im 3. Quartal, der älteste Biotechunternehmer läßt die Mitbewerber alt aussehen.